HIF-1α Is Essential for Effective PMN Bacterial Killing, Antimicrobial Peptide Production and Apoptosis in Pseudomonas aeruginosa Keratitis

PLoS Pathogens

Volumn 9, Issue 7, 2013, Pages

  Berger, Elizabeth A ^a   McClellan, Sharon A ^a   Vistisen, Kerry S ^a   Hazlett, Linda D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALVESPIMYCIN; CXCL2 CHEMOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; MYELOPEROXIDASE; NITRIC OXIDE; POLYPEPTIDE ANTIBIOTIC AGENT; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC SENSITIVITY; APOPTOSIS; ARTICLE; BACTERIAL KERATITIS; BACTERIAL LOAD; BACTERICIDAL ACTIVITY; CELL ISOLATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE SILENCING; IMMUNOHISTOCHEMISTRY; MOUSE; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PSEUDOMONAS INFECTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEREOMICROSCOPY;

EID: 84884745723     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003457     Document Type: Article

References (59)

1. Waring GO 3rd, Rodrigues MM, (1987) Patterns of pathologic response in the cornea. Surv Ophthalmol 84: 55-67.
2. Sbarra AJ, Karnovsky ML, (1959) The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem 234: 1355-1362.
3. Kepner W, (1939) The nature of leukemic blood cells as determined by their metabolism. J Clin Invest 18: 291-300.
4. Borregaard N, Herlin T, (1982) Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 70: 550-557.
5. Babior BM, (2000) Phagocytes and oxidative stress. Am J Med 109 (1) ():: 33-44.
6. Babior BM, (2000) The NADPH oxidase of endothelial cells. IUBMB Life 50: 267-269.
7. Hockel M, Vaupel P, (2001) Biological consequences of tumor hypoxia. Semin Oncol 28: 36-41.
8. Schaible B, Schaffer K, Taylor CT, (2010) Hypoxia, innate immunity and infection in the lung. Respir Physiol Neurobiol 174: 235-243.
9. Ikeda E, (2005) Cellular response to tissue hypoxia and its involvement in disease progression. Pathol Int 55: 603-610.
10. Leek RD, Harris AL, (2002) Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7: 177-189.
11. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE, (1999) Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66: 889-900.
12. Weisdorf KF, Craddock PR, Jacob HS, (1982) Granulocytes utilize different energy sources for movement and phagocytosis. Inflammation 6: 245-256.
13. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, et al. (2003) HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
14. Imtiyaz HZ, Simon MC, (2010) Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345: 105-120.
15. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, et al. (2005) HIF-1α expression regulates the bactericidal capacity of phagocytes. J Clin Invest 115: 1806-1815.
16. Hazlett LD, (2004) Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res 23: 1-30.
17. Wilhelmus KR, Keener MJ, Jones DB, Font RL, (1995) Corneal lipidosis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol 119: 14-19.
18. Yanoff M, Fine BS. (2002) Ocular pathology. St. Louis: Mosby, Inc.
19. Khan IA, Murphy PM, Casciotti L, Schwartzman JD, Collins J, et al. (2001) Mice lacking the chemokine receptor CCR1 show increased susceptibility to Toxoplasma gondii infection. 166: 1930-1937.
20. Nemzek JA, Bolgos GL, Williams BA, Remick DG, (2001) Differences in normal values for muring white blood cell counts and other hematological parameters based on sampling site. Inflamm Res 50: 523-527.
21. Kernacki KA, Barrett R, Hobden J, Hazlett LD, (2000) MIP-2 is a mediator of PMN influx in ocular bacterial infection. J Immunol 164: 1037-1045.
22. Hazlett LD, (2002) Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN and cytokines. DNA Cell Biol 21: 383-390.
23. Rudner XL, Kernacki KA, Barrett RP, Hazlett LD, (2000) Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates MIP-2 production, PMN persistence and corneal perforation. J Immunol 164: 6576-6582.
24. Lukashev D, Klebanov B, Kojima H, Grinberg A, Ohta A, et al. (2006) Cutting edge: hypoxia-inducible factor 1alpha and its activation-inducible short isoform I.1 negatively regulate functions of CD4+ and CD8+ T lymphocytes. J Immunol 177: 4962-4965.
25. Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS One 2: e853.
26. Hazlett LD, McClellan S, Kwon B, Barrett R, (2000) Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest Ophthalmol Vis Sci 41: 805-810.
27. McInturff AM, Cody MJ, Elliott EA, Glenn JW, Rowley JW, et al. (2012) Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 alpha. Blood 15: 3118-3125.
28. Foldenauer MEB, McClellan SA, Berger EA, Hazlett LD, (2013) mTOR regulates IL-10 and resistance to Pseudomonas aeruginosa corneal infection. J Immunol 190: 5649-58.
29. Fang HU, Hughes R, Murdoch C, Coffelt SB, Biswas SK, et al. (2009) Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood 114: 844-859.
30. Oda T, Hirota K, Nishi K, Takabuchi S, Oda S, et al. (2006) Activation of hypoxia-inducible factor 1 during macrophage differentiation. Am J Physiol Cell Physiol 291: C104-C113.
31. Peyssonnaux C, Cejudo-Martin P, Doedens A, Zinkernagel AS, Johnson RS, et al. (2007) Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J Immunol 178: 7516-7519.
32. Zinkernagel AS, Peyssonnaux C, Johnson RS, Nizet V, (2008) Pharmacologic augmentation of hypoxia-inducible factor-1alpha with mimosine boosts the bactericidal capacity of phagocytes. J Infect Dis 197: 214-217.
33. Szliter-Berger EA, Hazlett LD. (2010) Corneal epithelium: response to infection. In: Dartt DA, editor. Encyclopedia of the eye, vol 1. Oxford: Academic Press. pp. 442-448.
34. Wu M, McClellan SA, Barrett RP, Hazlett LD, (2009) Beta-defensin-2 promotes resistance against infection with P. aeruginosa. J Immunol 182: 1609-1616.
35. Wu M, McClellan SA, Barrett RP, Zhang Y, Hazlett LD, (2009) Beta-defensins 2 and 3 together promote resistance to Pseudomonas aeruginosa keratitis. J Immunol 183: 8054-8060.
36. Peyssonnaux C, Boutin AT, Zinkernagel AS, Datta V, Nizet V, et al. (2008) Critical role of HIF-1α in keratinocyte defense against bacterial infection. J Invest Dermatol 128: 1964-1968.
37. Kobayashi SD, Voyich JM, Whitney AR, DeLeo FR, (2005) Spontaneous neutrophil apoptosis and regulation of cell survival by granulocyte macrophage-colony stimulating factor. J Leukoc Biol 78: 1408-1418.
38. Brach MA, deVos S, Gruss H-J, Herrmann F, (1992) Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80: 2920-2924.
39. Zhou Z, Wu M, Barrett RP, McClellan SA, Zhang Y, et al. (2010) Role of the Fas pathway in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 51: 2537-2547.
40. Eyles JL, Roberts AW, Metcalf D, Wicks IP, (2006) Granulocyte colony-stimulating factor and neutrophils - forgotten mediators of inflammatory disease. Nat Clin Pract Rheumatol 2: 500-510.
41. Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleiszig SMJ, Wu C, Mende-Mueller L, Frank D, (1997) ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol 25: 547-557.
42. Yahr T, Mende-Mueller LM, Friese MB, Frank DW, (1997) Identification of type III secreted products of the Pseudomonas aeruginosa exoenzyme S regulon. J Bacteriol 179: 7165-7168.
43. Brinkmann V, Reichard U, Goosman C, Fauler B, Uhlemann Y, et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
44. Wartha F, Beiter K, Normark S, Henriques-Normark B, (2007) Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol 10: 52-56.
45. Jiang X, McClellan SA, Barrett RP, Berger EA, Zhang Y, Hazlett LD, (2012) VIP and growth factors in the infected cornea. Invest Ophthalmol Vis Sci 52: 6154-6161.
46. Gaudry M, Bregerie O, Andrieu V, El Benna J, Pocidalo MA, Hakim J, (1997) Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90: 4153-4161.
47. McCourt M, Wang JH, Sookhai S, Redmond HP, (2001) Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol 27: 396-403.
48. Semenza GL, (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578.
49. Chen P, Yin H, Wang Y, Wang Y, Xie L, (2012) Inhibition of VEGF expression and corneal neovascularization by shRNA targeting HIF-1α in a mouse model of closed eye contact lens wear. Mol Vis 18: 864-873.
50. Elks PM, van Eeden JF, Dixon G, Wang X, Reyes-Aldasoro CC, et al. (2011) Activation of hypoxia-inducible factor-1α (Hif-1α) delays inflammation resolution by reducing neutrophil apoptosis and reverse migration in a zebrafish inflammation model. Blood 118: 712-722.
51. Zarember KA, Malech HL, (2005) HIF-1α: a master regulator of innate host defenses? J Clin Invest 115: 1702-1704.
52. Hazlett LD, Moon MM, Strejc M, Berk RS, (1987) Evidence for N-acetylmannosamine as an ocular receptor for P. aeruginosa adherence to scarified cornea. Invest Ophthalmol Vis Sci 28: 1978-1985.
53. Lang SA, Moser C, Gaumann A, Klein D, Glockzin G, et al. (2007) Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth. Clin Cancer Res 13: 6459-6468.
54. Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, et al. (2007) Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Mol Cancer Ther 6: 1123-1132.
55. Luo Y. (1997) Isolation of mouse neutrophils. In: John Wiley and Sons, editors. Current protocols in immunology. New York. p3.20.1-3.20.6.
56. Szliter EA, Lighvani S, Barrett RP, Hazlett LD, (2007) Vasoactive intestinal peptide balances pro- and anti-inflammatory cytokines in the Pseudomonas aeruginosa-infected cornea and protects against corneal perforation. J Immunol 178: 1105-1114.
57. Roux KH, (1995) Optimization and troubleshooting in PCR. PCR Methods Appl 4: S185-194.
58. Williams RN, Paterson CA, Eakins KE, Bhattacherjee P, (1982) Quantification of ocular inflammation: evaluation of polymorphonuclear leucocyte infiltration by measuring myeloperoxidase activity. Curr Eye Res 2: 465-470.
59. Hazlett LD, Masinick-McClellan SA, Barrett RP, (1999) Complement defects in aged mice compromise phagocytosis of Pseudomonas aeruginosa. Curr Eye Res 19: 26-32.